Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06153485 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Automated Titration for Home Oxygen Therapy

StatusEnrolling by Invitation
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 4, 2025 (before its estimated July 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Dec 30, 2025 to Jul 30, 2026
    • Trial status: Recruiting to Enrolling by Invitation
    • Study completion date: Mar 31, 2026 to Dec 31, 2026
    • Site details revised
    v4
  2. Primary completion date: Sep 30, 2024 to Dec 30, 2025
    • Study completion date: Dec 30, 2024 to Mar 31, 2026
    v3
  3. Start date changed from estimate of Nov 27, 2023 to Dec 1, 2023v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Patients with chronic respiratory disease may be prescribed oxygen therapy. Currently, the dose of oxygen flow is fixed (FixedO2) depending on activity level i.e. rest, physical activity and sleep. Automated Titration of Oxygen (AutoO2) is a closed-loop system in which the oxygen flow to the patient is continuously machine adjusted to meet the patient's immediate needs on the basis of signals from pulse oximetry (SpO2). The purpose of this study is to examine if automated oxygen control based on pulse oximetry provided to participants is superior to prescribed fixed oxygen flow in keeping SpO2 within the intended target interval of 92 to 96% arterial oxygen saturation.
Trial Details
NCT Number NCT06153485
Lead Sponsor West Park Healthcare Centre
Conditions
(from sponsor)		 Chronic Respiratory Disease
Enrollment 25 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov